Bob Meek

2.3k citations

55 papers · 1.7k indexed · 1 hit paper · h-index 21

Impact in

Immunology top 5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Parasitology top 5%

Papers in

Immunology 17
- Immunodeficiency and Autoimmune Disorders 7
- Immune Cell Function and Interaction 6
Epidemiology 27
- Pneumonia and Respiratory Infections 13
- Respiratory viral infections research 8
- Pneumocystis jirovecii pneumonia detection and treatment 7

Co-authors: Sidonia Fagarasan Keiichiro Suzuki Tasuku Honjo Yasuko Doi Tsutomu Chiba Masamichi Muramatsu Jan C. Grutters Tsuneyasu Kaisho
Journals: Vaccine (4 papers)Clinical & Experimental Immunology (3 papers)European Respiratory Journal (2 papers)Diagnostic Microbiology and Infectious Disease (2 papers)Proceedings of the National Academy of Sciences (2 papers)
Partner nations: Netherlands Japan United States

In The Last Decade

Bob Meek

54 papers receiving 1.7k citations

Hit Papers

align trajectories log scale

Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut 2004 · 563 citations

Peers

Countries citing papers authored by Bob Meek

Since Specialization

Citations

This map shows the geographic impact of Bob Meek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bob Meek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bob Meek more than expected).

Fields of papers citing papers by Bob Meek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bob Meek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bob Meek. The network helps show where Bob Meek may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Bob Meek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bob Meek Line = papers co-authored together Bob Meek links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study Journal of Autoimmunity ·D. Doering, Ester M. van Leeuwen, Arab Kheradmand Ali, Anneke J. van der Kooi, Kyra A. Gelderman, Dörte Hamann, Ellen G. van Lochem, Bob Meek, Renate G. van der Molen, Riccardo Stolica, Henny G. Otten, Marco W.J. Schreurs, Joost Raaphorst	2023	2
2	Immunogenicity of the 13-valent pneumococcal conjugate vaccine followed by the 23-valent pneumococcal polysaccharide vaccine in people living with HIV on combination antiretroviral therapy International Journal of Antimicrobial Agents ·Mega Vidya, Jenny L Schnyder, Ella Bergmann-Michel, Albert M. Vollaard, Michael W.T. Tanck, Godelieve J. de Bree, Bob Meek, Martin P. Grobusch, Abraham Goorhuis	2022	8
3	Elevated Serum Amyloid a Levels Are not Specific for Sarcoidosis but Associate with a Fibrotic Pulmonary Phenotype Cells ·Tracie R. Porter, Mannucci Claudia, M. Miguel-Brebion, Jan C. Grutters, Bob Meek, Marcel Veltkamp	2021	23
4	A functional spleen contributes to afucosylated IgG in humans Scientific Reports ·Nikhil Phaniraj, David E. Schmidt, Володимир Васильович В. Завальнюк, Minke A.E. Rab, Bob Meek, Okke de Weerdt, Manfred Wuhrer, C. Ellen van der Schoot, Jaap Jan Zwaginga, Masja de Haas, David Falck, Gestur Vidarsson	2021	6
5	Altered splenic [89Zr]Zr-rituximab uptake in patients with interstitial lung disease not responding to rituximab: could this indicate a splenic immune-mediated mechanism? Utrecht University Repository (Utrecht University) ·سليم العايب, Bob Meek, E.M.W. van de Garde, Coline HM van Moorsel, Daniëlle J. Vugts, Ruth G.M. Keijsers, Jan C. Grutters	2020	5
6	Randomised, placebo-controlled trial of dexamethasone for quality of life in pulmonary sarcoidosis Respiratory Medicine ·Vikas Pratap, E.M.W. van de Garde, Bob Meek, Stephen J Roberts, Jan C. Grutters	2020	14
7	Immunoreactivity to metal and silica associates with sarcoidosis in Dutch patients Respiratory Research ·Tracie R. Porter, Bob Meek, Xavier Bossuyt, Susan Peters, Roel Vermeulen, Hans Kromhout, Marcel Veltkamp	2020	30
8	Sarcoidosis in a patient clinically diagnosed with silicosis; is silica associated sarcoidosis a new phenotype? Respiratory Medicine Case Reports ·Tracie R. Porter, Bob Meek, Hans Kromhout, H. Wouter van Es, Kees A. Seldenrijk, Marjolein Drent, Hardianti Purnama Sari, Marcel Veltkamp	2019	18
9	Frequencies and clinical associations of myositis-related antibodies in The Netherlands: A one-year survey of all Dutch patients SHILAP Revista de lepidopterología ·Anouk C. M. Platteel, Brigitte A. Wevers, Johan Lim, Jaap Bakker, Hetty J. Bontkes, Joyce Curvers, Jan Damoiseaux, Michiel Heron, Yongcun Wei, Maarten Limper, Ellen G. van Lochem, A. H. L. Mulder, Christiaan G. J. Saris, A’inun Jannah, Anneke J. van der Kooi, Ester M. M. van Leeuwen, Marcel Veltkamp, Marco W.J. Schreurs, Bob Meek, Dörte Hamann	2019	30
10	Rheumatoid factor isotype and Ro epitope distribution in primary Sjögren syndrome and rheumatoid arthritis with keratoconjunctivitis sicca Rheumatology International ·Bob Meek, Johannes C. Kelder, A.M.E. Claessen, A.J. van Houte, P. Corbishley	2018	12
11	Course of SP-D, YKL-40, CCL18 and CA 15-3 in adult patients hospitalised with community-acquired pneumonia and their association with disease severity and aetiology: A post-hoc analysis PLoS ONE ·Simone M.C. Spoorenberg, Stefan M.T. Vestjens, G. Paul Voorn, Coline H.M. van Moorsel, Bob Meek, Pieter Zanen, Ger T. Rijkers, Willem Jan W. Bos, Jan C. Grutters, (unknown)	2018	8
12	Pneumococcal conjugate vaccination response in patients after community-acquired pneumonia, differences in patients with S. pneumoniae versus other pathogens Vaccine ·Gertjan H.J. Wagenvoort, Bart J. M. Vlaminckx, Diana A. van Kessel, Joy Poulose, B.A.W. de Jong, Jan C. Grutters, Willem Jan W. Bos, Bob Meek, Ger T. Rijkers	2017	6
13	Case report on a defective antibody response against pneumococcal serotype 9V in a patient with a single episode of pneumonia SHILAP Revista de lepidopterología ·苏小定, Thijs W. Hoffman, Heleen van Velzen‐Blad, Bob Meek, 최재운, Jan C. Grutters, Ger T. Rijkers	2017	1
14	Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands Vaccine ·Stefan M.T. Vestjens, Gertjan H.J. Wagenvoort, Jan C. Grutters, Bob Meek, Hadeer Rashed Torky, Bart J. M. Vlaminckx, Willem Jan W. Bos, Ger T. Rijkers, E.M.W. van de Garde	2017	15
15	T cells fail to develop in the human skin-cell explants system; an inconvenient truth BMC Immunology ·Bob Meek, M. Buijzen, Mirelle J.A.J. Huijskens, María Angélica Navarro Martínez, Bernadetta Chyrchel, P. H. Belge, Joris Vanderlocht, Mark A. Kirkland, Maria J. Ferreira Alves, Wilfred T.V. Germeraad, Gerard M.J. Bos	2011	12
16	Klebsiella pneumoniae‐triggered DC recruit human NK cells in a CCR5‐dependent manner leading to increased CCL19‐responsiveness and activation of NK cells European Journal of Immunology ·Catharina Van Elssen, Joris Vanderlocht, Norma Klein, Birgit L.M.G. Senden-Gijsbers, Inna Rampasi, Michel van Gelder, Bob Meek, Christine Libon, Guido Ferlazzo, Wilfred T.V. Germeraad, Gerard M.J. Bos	2010	32
17	Regulation of B1 cell migration by signals through Toll-like receptors The Journal of Experimental Medicine ·Seon-Ah Ha, Masayuki Tsuji, Keiichiro Suzuki, Bob Meek, Nobutaka YASUDA, Tsuneyasu Kaisho, Sidonia Fagarasan	2006	235
18	Conserved regions of protein disulfide isomerase are targeted by natural IgA antibodies in humans International Immunology ·Bob Meek	2002	26
19	Herpes Simplex Virus Infection of the Human Eye Induces a Compartmentalized Virus‐Specific B Cell Response The Journal of Infectious Diseases ·Ron Peek, Georges M. G. M. Verjans, Bob Meek	2002	10
20	Dissecting the IgM antibody response during the acute and latent phase of toxoplasmosis Diagnostic Microbiology and Infectious Disease ·Bob Meek, Tom van Gool, Henk Gilis, Ron Peek	2001	18

About Bob Meek

Bob Meek is a scholar working on Immunology, Epidemiology, Parasitology, Physiology and Pulmonary and Respiratory Medicine, having authored 55 papers that have together received 1.7k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Pneumonia and Respiratory Infections (13 papers), Sarcoidosis and Beryllium Toxicity Research (11 papers), Respiratory viral infections research (8 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers), Immunodeficiency and Autoimmune Disorders (7 papers), Immune Cell Function and Interaction (6 papers) and Toxoplasma gondii Research Studies (5 papers). The work is most often cited by research in Immunology (662 citations), Parasitology (110 citations), Infectious Diseases (300 citations), Gastroenterology (65 citations) and Physiology (286 citations). Bob Meek has collaborated with scholars based in Netherlands, Japan and United States. Frequent co-authors include Sidonia Fagarasan, Keiichiro Suzuki, Tasuku Honjo, Yasuko Doi, Tsutomu Chiba, Masamichi Muramatsu, Jan C. Grutters, Tsuneyasu Kaisho, Nobutaka YASUDA and Seon-Ah Ha. Their work appears in journals such as Vaccine, Clinical & Experimental Immunology, European Respiratory Journal, Diagnostic Microbiology and Infectious Disease and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact